Results 141 to 150 of about 3,331 (189)

Combined oral contraceptive use as a cause of acute myocardial infarction in a young woman without traditional risk factors: a case report. [PDF]

J Med Case Rep
Hosseini SK, Mohammadi H, Mohammadi SA.
europepmc   +1 more source

Traditional herbal medicine for obesity-related polycystic ovary syndrome: a meta-analysis and data mining study. [PDF]

Front Pharmacol
Tang L, Liu H, Pang Y, Wang G, Wang Z, Lv T.   +5 more
europepmc   +1 more source

Virtual screening of drugs against multiple targets of Alzheimer's disease. [PDF]

J Alzheimers Dis
Ben Zaken K, Mesfin S, Bloch N, Samson AO.   +3 more
europepmc   +1 more source

Successful treatment of Heyan Kuntai capsule combined with hormonal therapy in an adolescent with diminished ovarian reserve: a case report. [PDF]

J Ovarian Res
Ao X, Xiong L, Zhu J, Tan S.
europepmc   +1 more source

Identifying psychiatric comorbidities that occur following the introduction of hormonal contraception: a scoping review. [PDF]

Front Psychiatry
Poirier A, Fortier J, Marin MF, Désilets M, Hudon A.   +4 more
europepmc   +1 more source

Analysis of Menopausal Hormone Therapy to Chinese Patients with Menopausal Syndrome: A Real-World Retrospective Study from Chinese Hospitals. [PDF]

Drug Des Devel Ther
Zhu Z, Shi A, Liu L, Jin G, Wang X.
europepmc   +1 more source

Drospirenone and its antialdosterone properties

Climacteric, 2007
Drospirenone is a unique progestogen derived from 17alpha-spirolactone, with a pharmacologic profile very similar to that of endogenous progesterone. In contrast with other available progestins, drospirenone is a progestogen with aldosterone receptor ...
Paolo Mannella, Tommaso Simoncini
exaly   +1 more source

Pharmacology of different progestogens: the special case of drospirenone

Climacteric, 2005
The pharmacological properties of progestins used in contraception and hormone replacement therapy (HRT) vary, depending upon the molecules from which they are derived. Very small structural changes may induce considerable differences in effects.
R Sitruk-Ware
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Drospirenone/ethinyl estradiol

Drugs of Today, 2008
Drospirenone 3 mg/ethinyl estradiol 20 microg (24/4) is a new unique oral contraceptive formulation that combines in a novel dosing regimen the lowest dosage of ethinyl estradiol commonly used today with drospirenone, an innovative progestin.
Andrea J, Rapkin, Shelley N, Sorger, Sharon A, Winer   +2 more
openaire   +2 more sources

Drospirenone: a novel progestin

Expert Opinion on Pharmacotherapy, 2007
Drospirenone is a novel progestin available in combined oral contraceptives and menopausal hormonal therapy. Similar to its parent compound spirolactone, an analog of spironolactone, drospirenone has antimineralocorticoid and antiandrogenic activity.
Andrea J, Rapkin, Sharon A, Winer
openaire   +2 more sources